It is composed of three amino acids: L-glutamic acid, cysteine, and glycine
Improved physiochemical and pharmacological properties are often cited as a key motivation for the discovery of molecular glues over heterobifunctionals
The search strategy targeted studies involving GLP-1 receptor agonists (e.g., exenatide, liraglutide, dulaglutide, lixisenatide, benaglutide, loxenatide, semaglutide) and multi-target receptor agonists (e.g., tirzepatide), focusing on gastrointestinal adverse events (e.g., nausea, vomiting, diarrhea, constipation, dyspepsia, and reduced appetite) in patients with type 2 diabetes mellitus (T2DM) (Supplementary Material)
Tell your clinician about any such history
The goal is to improve patient outcomes through a mix of medical and behavioral methods
BIOAKTIVE FORM - wir verwenden Glutathion als bioaktives, reduziertes L-Glutathion